Since 2003 Cureline has been dedicated to innovation
in human tissue research and precision medicine.
For over twenty years Cureline Team have been developing global collaborations and protocols for obtaining, handling, processing, and analyzing human biospecimens (HBS) worldwide. We started this business when targeted medicine was in its cradle, “precision medicine” term was not yet in use, and “biomarker assay” was an early protagonist of “companion diagnostics”. Every year our procurement network expands to new therapeutic areas and new territories: over the years we have conducted our studies in 20 countries on four continents and supported over 700 clients with 4,000+ successfully conducted projects.
Cureline Group HQ and HBS biorepository are located in the San Francisco Bay since inception in 2003. Members of Cureline management team are highly motivated and well-trained life sciences experts, international business, clinical research and medical professionals. We aim at being involved in your biomarker R&D, companion Dx, clinical research and development process not only as a service provider but also as your trusted collaborator. With our experience and knowledge, we understand our clients research goals and act as an ideal partner for your scientific programs.
Please visit the ABS Bio Leadership page.
Special biospecimen collection protocols:
- Primary cell lines from solid tumors, hematological cancers and normal ticcues
- Viable epitope - specific cell fractions from blood and bone marrow
- Procurement of biospecimen sets (tissue biopsy, synovial fluid, PBMCs, serum, eyc.) from patients with inflammatory diseases (rheumatoid arthritis, lupus, etc.)
- Specimens with longitudinal data (clinical outcome and treatment efficacy)
- Custom protocol transfer and speciemns processing using client's drug candidates (solid tissues, blood, other biofluids)
Standards & most challenging human biospecimen collections
Contact us
For over twenty years Cureline Team have been developing global collaborations and protocols for obtaining, handling, processing, and analyzing human biospecimens (HBS) worldwide. We started this business when targeted medicine was in its cradle, “precision medicine” term was not yet in use, and “biomarker assay” was an early protagonist of “companion diagnostics”. Every year our procurement network expands to new therapeutic areas and new territories: over the years we have conducted our studies in 20 countries on four continents and supported over 700 clients with 4,000+ successfully conducted projects.
Cureline Group HQ and HBS biorepository are located in the San Francisco Bay since inception in 2003. Members of Cureline management team are highly motivated and well-trained life sciences experts, international business, clinical research and medical professionals. We aim at being involved in your biomarker R&D, companion Dx, clinical research and development process not only as a service provider but also as your trusted collaborator. With our experience and knowledge, we understand our clients research goals and act as an ideal partner for your scientific programs.
Please visit the ABS Bio Leadership page.
Special biospecimen collection protocols:
- Primary cell lines from solid tumors, hematological cancers and normal ticcues
- Viable epitope - specific cell fractions from blood and bone marrow
- Procurement of biospecimen sets (tissue biopsy, synovial fluid, PBMCs, serum, eyc.) from patients with inflammatory diseases (rheumatoid arthritis, lupus, etc.)
- Specimens with longitudinal data (clinical outcome and treatment efficacy)
- Custom protocol transfer and speciemns processing using client's drug candidates (solid tissues, blood, other biofluids)
Standards & most challenging human biospecimen collections